Currently, much evidence supports NAMPT and the NAMPT-NAD+ biosynthesis pathway as therapeutic targets against ischemic stroke, including neuroprotection, vascular repair, and neurogenesis [8, 10, 18]. Here, NAMPT is linked to ischemic stroke.